USFDA issues 3 observations for Biocon Visakhapatnam API facility Ruchika Sharma16 Jun 2024 11:00 AM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded...
Takeda signs option agreement with Ascentage Pharma to enter into exclusive global license for Olverembatinib Ruchika Sharma16 Jun 2024 10:30 AM ISTJapan: Takeda has announced the signing of an option agreement with Ascentage Pharma to enter into an exclusive license agreement for...
JP Nadda, Anupriya Patel preside over review meeting of Department of Pharmaceuticals Ruchika Sharma15 Jun 2024 5:32 PM ISTNew Delhi: Union Minister for Chemicals & Fertilizers, Shri Jagat Prakash Nadda along with MoS (Chemicals & Fertilizers), Ms. Anupriya...
USFDA approves Bristol Myers Squibb Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid Tumors Ruchika Sharma15 Jun 2024 4:26 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...
Suven Pharma to buy 67.5 percent stake in Sapala Organics for Rs 229.5 crore Ruchika Sharma15 Jun 2024 2:56 PM ISTMumbai: Suven Pharmaceuticals has announced that the Company will acquire 67.5 per cent stake in Sapala Organics Private Limited for Rs 229.5...
Sun Pharma, Moebius Medical present positive data from phase 2b trial of MM-II in painful knee osteoarthritis patients at EULAR 2024 Ruchika Sharma15 Jun 2024 12:30 PM ISTSun Pharma and Moebius Medical, who have been jointly developing MM-II, have announced plans to initiate a Phase 3 clinical program.
KMV Narayana Rao appointed as Vice President - ARD at NATCO Research Centre Ruchika Sharma15 Jun 2024 11:56 AM ISTHyderabad: Through a recent BSE filing, Natco Pharma has informed that K.M.V. Narayana Rao has been appointed as Vice President - ARD at NATCO...
Bayer gets Breakthrough Therapy designation in China for lung cancer drug BAY 2927088 Ruchika Sharma15 Jun 2024 10:00 AM ISTBerlin: Bayer has announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China has...
Pfizer Duchenne gene therapy fails to meet primary end point in Phase 3 CIFFREO trial Ruchika Sharma14 Jun 2024 5:23 PM ISTNew York: Pfizer Inc. has announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating...
Zydus Lifesciences bags USFDA tentative nod for Azilsartan Medoxomil and Chlorthalidone Tablets for hypertension Ruchika Sharma14 Jun 2024 4:02 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Lupin Nagpur Injectable facility concludes USFDA inspection with zero 483 observations Ruchika Sharma14 Jun 2024 12:33 PM ISTMumbai: Global pharma major Lupin Limited today announced that the United States Food and Drug Administration (U.S. FDA) has completed an...
AstraZeneca Farxiga gets USFDA nod for paediatric type 2 diabetes Ruchika Sharma14 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) for the improvement of...
